Cargando…
Consensus statement on the current pharmacological prevention and management of heart failure
Introduction: This consensus statement of Australian clinicians provides new recommendations for the pharmacological management of heart failure based on studies reported since the publication of the 2018 Australian heart failure guidelines. Main recommendations: ▪. Use of sodium–glucose cotransport...
Autores principales: | Sindone, Andrew P, De Pasquale, Carmine, Amerena, John, Burdeniuk, Christine, Chan, Alicia, Coats, Andrew, Hare, David L, Macdonald, Peter, Sverdlov, Aaron, Atherton, John J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545515/ https://www.ncbi.nlm.nih.gov/pubmed/35908234 http://dx.doi.org/10.5694/mja2.51656 |
Ejemplares similares
-
Sodium‐glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review
por: Rasalam, Roy, et al.
Publicado: (2021) -
Italian national consensus statement on management and pharmacological treatment of phenylketonuria
por: Burlina, Alberto, et al.
Publicado: (2021) -
It is time for consensus on ‘consensus statements’
por: Blazey, Paul, et al.
Publicado: (2022) -
International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL
por: Awan, Farrukh T., et al.
Publicado: (2022) -
JAG consensus statements for training and certification in oesophagogastroduodenoscopy
por: Siau, Keith, et al.
Publicado: (2022)